These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 36080455)

  • 1. New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation.
    El-Sayed WA; Alminderej FM; Mounier MM; Nossier ES; Saleh SM; F Kassem A
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2.
    El-Sayed WA; Alminderej FM; Mounier MM; Nossier ES; Saleh SM; Kassem AF
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
    Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
    Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis and Cytotoxicity of New Coumarin-1,2,3-triazole Derivatives: Evaluation of Anticancer Activity and Molecular Docking Studies.
    Premsagar Miriyala V; Raj Thommandru P; Kashanna J; Govinda V; Ravi G; Kishore R
    Chem Biodivers; 2023 Jul; 20(7):e202300269. PubMed ID: 37204157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, Synthesis, Anticancer Activity and Molecular Docking of New 1,2,3-Triazole-Based Glycosides Bearing 1,3,4-Thiadiazolyl, Indolyl and Arylacetamide Scaffolds.
    Elganzory HH; Alminderej FM; El-Bayaa MN; Awad HM; Nossier ES; El-Sayed WA
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
    Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Cytotoxic Activity of New 1,3,4-Thiadiazole Thioglycosides and 1,2,3-Triazolyl-1,3,4-Thiadiazole
    Alminderej FM; Elganzory HH; El-Bayaa MN; Awad HM; El-Sayed WA
    Molecules; 2019 Oct; 24(20):. PubMed ID: 31623291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.
    Kraljević TG; Harej A; Sedić M; Pavelić SK; Stepanić V; Drenjančević D; Talapko J; Raić-Malić S
    Eur J Med Chem; 2016 Nov; 124():794-808. PubMed ID: 27639370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
    El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
    Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
    Ihmaid SK; Alraqa SY; Aouad MR; Aljuhani A; Elbadawy HM; Salama SA; Rezki N; Ahmed HEA
    Bioorg Chem; 2021 Jun; 111():104835. PubMed ID: 33798850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR/VEGFR-2 dual inhibitor and apoptotic inducer: Design, synthesis, anticancer activity and docking study of new 2-thioxoimidazolidin-4one derivatives.
    Mourad AAE; Farouk NA; El-Sayed EH; Mahdy ARE
    Life Sci; 2021 Jul; 277():119531. PubMed ID: 33887348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Click chemistry based synthesis, cytotoxic activity and molecular docking of novel triazole-thienopyrimidine hybrid glycosides targeting EGFR.
    Khattab RR; Alshamari AK; Hassan AA; Elganzory HH; El-Sayed WA; Awad HM; Nossier ES; Hassan NA
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):504-516. PubMed ID: 33504239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
    Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B
    Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity.
    Maghraby MT; Mazyad Almutairi T; Bräse S; Salem OIA; Youssif BGM; Sheha MM
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies.
    Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells.
    Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA
    Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of morpholines linked coumarin-triazole hybrids as anticancer agents.
    Goud NS; Pooladanda V; Mahammad GS; Jakkula P; Gatreddi S; Qureshi IA; Alvala R; Godugu C; Alvala M
    Chem Biol Drug Des; 2019 Sep; 94(5):1919-1929. PubMed ID: 31169963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical profiling, cytotoxic activities through apoptosis induction in human fibrosarcoma and carcinoma cells, and molecular docking of some 1,2,3-triazole-isoxazoline hybrids using the eugenol as a precursors.
    Oubella A; Taia A; Byadi S; Ait Lahcen M; Bimoussa A; Essaber M; Podlipnik C; Morjani H; Ait Itto MY; Aatif A
    J Biomol Struct Dyn; 2023 Apr; 41(7):2759-2771. PubMed ID: 35174765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial agents.
    Pingaew R; Saekee A; Mandi P; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Eur J Med Chem; 2014 Oct; 85():65-76. PubMed ID: 25078311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.